Boston Globe -- Merck & Co says it has failed to win federal approval to expand use of the cervical-cancer vaccine Gardasil to older women. The Food and Drug Administration didn’t grant the application from Merck to market the drug to women ages 27 to 45, Merck said yesterday on its website.
